Aminosalicylic acid is bacteriostatic against Mycobacterium tuberculosis. It inhibits the onset of bacterial resistance to streptomycin and isoniazid.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
4-Aminosalicylic acid is the active ingredient of these drugs:
Austria Finland France Ireland Lithuania
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):